OMNIQ 1H Sales $50M
OMNIQ’s 2022 continuous momentum:
54% growth in 6 month Revenue marks an all-time record of over $50 Million.
104% growth in 6 Month Gross Profit up to a record of over $12M.
85% Growth in Q2 Revenue compared
AIM ImmunoTech Q2 EPS $(0.10) Up From $(0.12) YoY
AIM ImmunoTech (AMEX:AIM) reported quarterly losses of $(0.10) per share. This is a 16.67 percent increase over losses of $(0.12) per share from the same period last year.
Team Q2 EPS $(0.36) Up From $(0.48) YoY, Sales $251.30M Up From $238.87M YoY
Team (NYSE:TISI) reported quarterly losses of $(0.36) per share. This is a 25 percent increase over losses of $(0.48) per share from the same period last year. The company reported $251.30 million in sales this quarter.
Singularity Future Technology Ltd. Filing Discloses On Aug. 9, Yang Jie Tendered Resignation From CEO Position
On August 9, 2022, Mr. Yang Jie tendered his resignation from his positions as the Chief Executive Officer (“CEO”) and director of Singularity Future Technology Ltd. (the “Company”) to the
USA University of Michigan Consumer Sentiment for Aug 55.100 vs 52.500 Est; Prior 51.500
USA University of Michigan Consumer Sentiment for Aug 55.100 vs 52.500 consensus estimate. The prior reading was 51.500.
Novavax Nuvaxovid COVID-19 Vaccine Approved In South Korea For Use In Adolescents Aged 12 Through 17
GAITHERSBURG, Md., Aug. 12, 2022 /PRNewswire/ -- Novavax, Inc. (NASDAQ:NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced
SilverSun Technologies Q2 EPS $(0.02) Down From $0.03 YoY, Sales $10.64M Up From $10.23M YoY
SilverSun Technologies (NASDAQ:SSNT) reported quarterly losses of $(0.02) per share. This is a 166.67 percent decrease over earnings of $0.03 per share from the same period last year. The company reported $10.64 million